DXCM vs PAPL · P/E 63, rev $2.50B vs rev $3.0M
DexCom Inc (DXCM) versus Pineapple Financial Inc. (PAPL) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Pineapple Financial Inc. (PAPL) is a mortgage finance company listed on AMEX.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported PAPL revenue for 2025-08-31 was $3.0M. Net income was -$3.6M. Revenue was up 11.1% from 2024-08-31 to 2025-08-31. PAPL currently screens at market cap $27.9M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. PAPL currently screens at market cap $27.9M.
Not investment advice. Open the DXCM and PAPL stock pages for the full models.
Not investment advice.